
Mibor 3.5 Injection



₹4426

Save more with additional offers









General Information



Product introduction
Mibor 3.5 Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Fatigue, nausea, vomiting, and loss of appetite are some common side effects of this medicine. You may be advised to drink plenty of fluids every day during the treatment. You should not drive or operate machinery as medicine may cause tiredness and dizziness. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.
Before taking Mibor 3.5 Injection, consult with your doctor if you have any liver, kidney, heart disease or bleeding problem. It is important to consult a doctor if you develop symptoms like memory loss or trouble in thinking. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
Uses of Mibor Injection
Benefits of Mibor Injection
Mibor 3.5 Injection is used in multiple myeloma to help control the growth of abnormal plasma cells in the bone marrow, reduce symptoms, and improve response to treatment.
In mantle-cell lymphoma, Mibor 3.5 Injection is used to slow the progression of the disease, reduce tumor burden, and enhance the effectiveness of combination cancer therapies.
Side effects of Mibor Injection
- Decreased white blood cell count (lymphocytes)
- Lymphopenia
- Decreased sodium level in blood
- Decreased calcium level in blood
- Low blood platelets
- Anemia (low number of red blood cells)
How to use Mibor Injection
How Mibor Injection works
All substitutes for Mibor 3.5 Injection
Bortenat 3.5mg Injection
Borzomed 3.5mg Injection
Borviz 3.5 Injection
Bortero 3.5mg Injection
Quick tips
- Mibor 3.5 Injection is given as an injection into veins or skin under the supervision of a healthcare professional.
- Do not skip any dose and complete the course as suggested by your doctor.
- Use an effective method of birth control to avoid pregnancy while taking this medication.
- You may need to have blood tests to monitor your blood cells, platelets count, liver function and kidney function during treatment.
- Inform your doctor immediately if you experience coughing, shortness of breath and swelling of feet.
Safety advice

Alcohol

Pregnancy

Breast feeding

Driving
Mibor 3.5 Injection might cause tiredness, dizziness, fainting, or blurred vision which may affect your ability to drive.

Kidney

Liver
Interaction with drugs
Carbamazepine (Oral Route)
Enzalutamide (Oral Route)
Fosphenytoin (Injection Route)
Phenytoin (Oral Route)
Phenytoin (Injection Route)
Frequently asked questions
Fact Box
Chemical Class
Habit Forming
Therapeutic Class
Action Class
Related lab tests
References
- Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1742-43.
- Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 958.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 153-54.
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:
- Bortezomib. Beerse Belgium: Janssen Pharmaceutica NV; [Accessed 26 Mar. 2019] (online) Available from:
- Bortezomib [Prescribing Information]. Cambridge, MA: Millennium Pharmaceuticals, Inc.; 2008. [Accessed 25 Jul. 2024] (online) Available from:
- Bortezomib. Visakhapatnam, Andhra Pradesh: Gland Pharma Limited; 2026. [Accessed 15 Apr. 2026] (online). Available from:





Want to know more
We provide you with authentic, trustworthy and relevant informationHave issue with the content
Disclaimer
Marketer details
Address: Plot No 264, Patrika Nagar Madhapur, Hitech City Hyderabad, Telangana India - 500081
Vendor Details
Lab tests offered by us
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)















